◼ Archived
Health
🔮 fades ✓
CRISPR makes prostate cancer vulnerable to immunotherapy
CRISPR editing turns immune‑cold prostate tumors into immunotherapy targets, sparking a new treatment direction.
Crispr
3 independently checked trend briefs about this subject, newest first.
What this Crispr timeline shows
headlinez.news detected 3 source-qualified news clusters connected to Crispr between June 25, 2026 and July 27, 2026. They span 2 newsroom categories and average 4.7 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
◼ Archived
Science
🔮 fades ✓
Precise DNA base editing using AlphaFold3-based contact modelling
Researchers are utilizing AlphaFold3-based contact modelling to redesign gene-editing proteins, aiming to improve safety in CRISPR applications.
◼ Archived
Health
🔮 fades ✓
‘Edited’ human embryos reveal secrets of our development
Researchers have identified a master gene responsible for human development while simultaneously advancing CRISPR techniques for embryo editing.